Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Human psychopharmacology

• Publication date

  2004-10-01

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1002/hup.613PMID 15378678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissociative effects of scopolamine on working memory in healthy young volunteers

  2005cited by this paper
• Acute nicotinic blockade produces cognitive impairment in normal humans

  2005influential reference
• The separate and combined effects of scopolamine and nicotine on human information processing

  2004cited by this paper
• The effects of scopolamine on working memory in healthy young volunteers

  2004cited by this paper
• Visual inspection time in Parkinson's disease: deficits in early stages of cognitive processing.

  2004cited by this paper
• The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

  2003influential reference
• Muscarinic receptors couple to modulation of nicotinic ACh receptor desensitization in myenteric neurons.

  2003cited by this paper
• Nicotinic receptors and Alzheimer's disease

  2003cited by this paper
• Serotonin selective antidepressants and early information processing

  2003cited by this paper
• Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology.

  2003cited by this paper
• Scopolamine impairs human recognition memory: data and modeling.

  2003cited by this paper
• Effects of Scopolamine on Matching to Sample Paradigm and Related Tests in Human Subjects

  2003influential reference
• Understanding the pathology of schizophrenia: recent advances from the study of the molecular architecture of postmortem CNS tissue

  2002cited by this paper
• Modulation of the Critical Flicker Fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes

  2002cited by this paper
• The visual backward masking deficit in schizophrenia.

  2001cited by this paper
• Neurophysiologic mechanisms of attention: a selective review of early information processing in schizophrenics.

  2001cited by this paper
• Mecamylamine: new therapeutic uses and toxicity/risk profile.

  2001cited by this paper
• Cholinergic modulation of speed of early information processing: the effect of donepezil on inspection time

  2001cited by this paper
• Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.

  2001cited by this paper
• The effect of cholinergic receptor blockade by scopolamine on memory performance and the auditory P3

  2000cited by this paper
• Effects of the nicotinic antagonist mecamylamine on inspection time

  2000influential reference
• EEG Changes following Scopolamine Administration in Healthy Subjects

  1999cited by this paper
• Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders.

  1999cited by this paper
• The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.

  1998cited by this paper
• A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

  1998cited by this paper
• Backward masking in schizophrenia: time course of visual processing deficits during task performance.

  1998cited by this paper
• Combined Nicotinic and Muscarinic Blockade in Elderly Normal Volunteers: Cognitive, Behavioral, and Physiologic Responses

  1998influential reference
• Effects of mecamylamine on spontaneous EEG and performance in smokers and non-smokers.

  1997influential reference
• Cognitive and Behavioral Effects of Cholinergic, Dopaminergic, and Serotonergic Blockade in Humans

  1997cited by this paper
• The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial

  1996cited by this paper
• Intelligence and inspection time: Achievements, prospects, and problems.

  1996cited by this paper
• The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

  1996cited by this paper
• Effects of nicotine on perceptual speed

  1995influential reference
• Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze.

  1995cited by this paper
• Age-Related Effects of the Nicotinic Antagonist Mecamylamine on Cognition and Behavior

  1994influential reference
• The effects of scopolamine on event-related potentials in a continuous recognition memory task.

  1992cited by this paper
• Inspection time, psychometric intelligence and clinical estimates of cognitive ability in pre-senile Alzheimer's disease and Korsakoff's psychosis.

  1991cited by this paper
• Atropine, scopolamine and related antimuscarinic drugs

  1990cited by this paper
• Characterization of the cognitive effects of combined muscarinic and nicotinic blockade.

  1990cited by this paper
• Reductions in acetylcholine and nicotine binding in several degenerative diseases.

  1988influential reference
• An investigation of the range of cognitive impairments induced by scopolamine 0·6 mg s.c

  1988influential reference
• Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats.

  1988cited by this paper
• Transdermal hyoscine (Scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

  1985cited by this paper
• The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.

  1985cited by this paper
• Repeated dose comparison of nomifensine, imipramine and placebo on subjective assessments of sleep and objective measures of psychomotor performance.

  1977cited by this paper

• Augmenting cognitive work: a review of cognitive enhancement methods and applications for operational domains

  2022cites this paper
• The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review

  2022cites this paper
• Can the Brain Be Relativistic?

  2021cites this paper
• Visual processing speed in freezing and non-freezing Parkinson’s disease patients

  2020cites this paper
• Effects of Nicotine Gum Administration on Vision (ENIGMA-Vis): Study Protocol of a Double-Blind, Randomized, and Controlled Clinical Trial

  2020cites this paper
• Comparative physiology and efficacy of atropine and scopolamine in sarin nerve agent poisoning.

  2020cites this paper
• CHRM2 Genotype Affects Inhibitory Control Mechanisms During Cognitive Flexibility

  2019cites this paper
• An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.

  2018cites this paper
• Reduced Prefrontal Short—Latency Afferent Inhibition in Older Adults and Its Relation to Executive Function: A TMS-EEG Study

  2017cites this paper
• An anti‐nicotinic cognitive challenge model using mecamylamine in comparison with the anti‐muscarinic cognitive challenge using scopolamine

  2017cites this paper
• Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task

  2017cites this paper
• EEG machine learning for accurate detection of cholinergic intervention and Alzheimer’s disease

  2017cites this paper
• Rejuvenating procholinergic treatments for cognition enhancement in AD: current challenges and future prospects

  2015cites this paper
• Aufmerksamkeits- und Arbeitsgedächtnisleistung nikotinabhängiger paranoid-schizophrener Patienten unter dem Einfluss von Nikotinkarenz bzw. -zufuhr sowie in Abhängigkeit der Affinität ihres Atypischen Antipsychotikums zum muskarinergen M1-Rezeptor

  2015cites this paper
• Leveraging the cortical cholinergic system to enhance attention.

  2013cites this paper
• Acetylcholine Deficiency in Caenorhabditis elegans Induced by Hyperthermia Can Be Compensated by ACh-esterase Inhibition or Activation of GAR-3 mAChRs

  2013cites this paper
• Effects of Pro-Cholinergic Treatment in Patients Suffering from Spatial Neglect

  2013cites this paper
• Bipolar Disorder: Clinical Perspectives and Implications with Cognitive Dysfunction and Dementia

  2012cites this paper
• Perturbação afectiva bipolar, disfunção cognitiva e demência

  2012cites this paper
• Y-Maze memory task in zebrafish (Danio rerio): the role of glutamatergic and cholinergic systems on the acquisition and consolidation periods.

  2012cites this paper
• Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging

  2011cites this paper
• Modes and Models of Forebrain Cholinergic Neuromodulation of Cognition

  2011influential citation
• Acute effects of donepezil in healthy young adults underline the fractionation of executive functioning

  2011cites this paper
• Treating schizophrenia: novel targets for the cholinergic system.

  2010cites this paper
• Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study

  2010cites this paper
• Role of the cholinergic system in the pathology and treatment of schizophrenia

  2009cites this paper
• Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory

  2009cites this paper
• Effects of dimethylaminoethanol pyroglutamate (DMAE p-Glu) against memory deficits induced by scopolamine: evidence from preclinical and clinical studies

  2009cites this paper
• Identifying and treating cognitive impairment in bipolar disorder.

  2009cites this paper
• Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women.

  2008cites this paper
• Beyond In Vitro Data: A Review of In Vivo Evidence Regarding the Allosteric Potentiating Effect of Galantamine on Nicotinic Acetylcholine Receptors in Alzheimer's Neuropathology

  2007cites this paper
• Gαq-Coupled Muscarinic Acetylcholine Receptors Enhance Nicotinic Acetylcholine Receptor Signaling in Caenorhabditis elegans Mating Behavior

  2007cites this paper
• Current awareness in human psychopharmacology

  2005cites this paper
• Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.

  2005influential citation
• Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.

  2005cites this paper